The Korean Journal of Gastroenterology :eISSN 2233-6869 / pISSN 1598-9992

 

Table. 2.

Changes in the CDAI and Its Components 6 Months after Taking S. boulardii (n=95)

Initiation After 3 months After 6months p-valuea



Mean SD Mean SD Mean SD
CDAI 40.65 53.65 37.60 47.84 32.06 50.29 <0.01
Body weight scoreb -5.70 17.11 -6.59 18.14 -8.15 19.38 <0.01
Hematocrit scorec 5.50 6.12 4.64 4.64 3.94 4.63 <0.01
Number of liquid or very soft stools per week 2.28 5.98 3.26 7.40 2.95 6.87 0.37
Abdominal pain 0.15 0.44 0.18 0.46 0.17 0.46 0.61
General well-being 0.06 0.25 0.07 0.25 0.08 0.28 0.16
Extra-gastrointestinal symptoms 0 0 0.01 0.10 0 0 1.00
Anti-diarrhea drug 0.01 0.10 0.01 0.10 0.01 0.10 1.00
Abdominal mass 0 0 0 0 0 0 1.00

CDAI, Crohn’s disease activity index; S. boulardii, Saccharomyces boulardii; SD, standard deviation.

aComparing baseline point to the 6-month time-point; b(Ideal body weight-observed body weight)/ideal body weight×100; cExpected hematocrit (men: 47, women: 42)-observed hematocrit.

Korean J Gastroenterol 2020;76:314~321 https://doi.org/10.4166/kjg.2020.115
© Korean J Gastroenterol